Search results
Results from the WOW.Com Content Network
miraDry is a microwave-based medical device developed by Miramar Labs which is used in the treatment of axillary hyperhidrosis. [1] It was approved by the United States Food and Drug Administration (FDA) in 2011 and was also approved in Europe. [1] miraDry selectively destroys axillary sweat glands without affecting the superficial layers of ...
In July 2016, the US Food and Drug Administration (FDA) approved abobotulinumtoxinA (Dysport) for injection for the treatment of lower-limb spasticity in pediatric patients two years of age and older. [53] [54] AbobotulinumtoxinA is the first and only FDA-approved botulinum toxin for the treatment of pediatric lower limb spasticity. [55]
Focal hyperhidrosis, also known as primary hyperhidrosis, is a disease characterized by an excessive sweating localized in certain body regions (particularly palms, feet and underarms). Studies suggest that this condition, affecting between 1% and 3% of the US population, seems to have a genetic predisposition in about two thirds of those affected.
An earlier petition by Public Citizen in 2008 based on an analysis of 180 reports led to the FDA adding the current black box warning about the risk of Botox's effect spreading to other areas of ...
I tried Daxxify, the new Botox alternative for smoothing fine lines that supposedly lasts longer than the competition. Here's what dermatologists had to say:
Sofpironium bromide, sold under the brand name Ecclock among others, is a medication used to treat hyperhidrosis (excessive sweating). [1] Sofpironium bromide is an anticholinergic agent that is applied to the skin. [1] It was approved for medical use in Japan in 2020, [2] and in the United States in June 2024. [1] [3] [4] [5]
Allergan, which markets ocular-care products, purchased the rights to Oculinum in order to service the "niche population" of stabismus patients, for $9M. Botox received FDA approval for cosmetic treatments in 2002. However, the majority of the drug's sales are made for therapeutic treatments. [16]
The FDA said there are several ways to identify counterfeit Botox products: The outer carton and vial contain lot number C3709C3. The outer carton displays the active ingredient as "Botulinum ...